Cooper University Health Care – home to South Jersey’s only dedicated Aortic Center-is among the first in the nation to offer the Nellix® Endovascular Aneurysm Sealing System offered through Endologix.
New, investigational Nellix® EVAS system is a new generation of AAA, abdominal aortic aneurysm therapy that is designed to seal the entire aneurysm with a biocompatible polymer. Nellix® is the first and only of its kind. It was developed to simplify procedures, reduce re-interventions and expand the treatable patient population.
Jeffrey Carpenter, MD., Chairman and Chief of Surgery for Cooper University Health Care is the study’s Global Principal Investigator. Dr. Carpenter stated, “The unique ability of Nellix® to seal the entire aneurysm sac is breakthrough technology and is the first meaningful advancement in AAA repair since endovascular grafts were introduced back in the late 1990’s. We believe Nellix® has the potential to dramatically change the way we treat AAA.”
“Cooper is excited to be among the initial centers in the country to have access to the first major innovation since the beginning of endovascular aneurysm repair,” according to Dr. Jose Trani, Principal Investigator of the study. “We believe that this device will likely change the way aneurysms are repaired in the future and feel that this new device (Nellix) offers significant improvement over currently available aneurysm repair systems.”
Read story here:
Market Watch